PROVIDER PROFILE · NPI 1821250994

Mohsin Mir

PRACTICELABORATORY CORPORATION OF AMERICASee all providers at this practice →

DermatologyHouston, TXI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

705

Beneficiaries

—

Total drug cost

$4K

Distinct drugs

Brand share

20.6%

Top prescribed drugs

Cephalexin263 claims

Tramadol Hcl/Acetaminophen145 claims

Doxycycline Hyclate121 claims

Mupirocin94 claims

Ciprofloxacin Hcl57 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Mohsin Mir's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Baylor Dermatopathology Laboratory Clinical Laboratory · Houston, TX	110	225
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Houston, TX	31	91
CHI ST. LUKE'S HEALTH BAYLOR COLLEGE OF MEDICINE MEDICAL CENTER	27	50
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	16	25
Carina Wasko Dermatology · Houston, TX	12	18

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history